Transdermal Delivery of Polymeric Nanoparticles Containing Aconite Root for the Treatment of Chemotherapy-Induced Peripheral Neuropathy

IF 4 Q2 ENGINEERING, BIOMEDICAL

Advanced Nanobiomed Research Pub Date : 2024-05-31 DOI:10.1002/anbr.202470051

Tae Eon Park, Man-Suk Hwang, Ki Su Kim

引用次数: 0

Abstract

Transdermal Nanomedicine

The chemotherapy-induced peripheral neuropathy (CIPN) caused by anticancer drugs results in severe pain for patients. In article number 2400006, Tae Eon Park, Man-Suk Hwang, and Ki Su Kim have developed hyaluronic acid-based polymeric nanoparticles containing natural herb extracts to alleviate neuropathic pain caused by CIPN. These particles are delivered non-invasively through the skin, contributing to nerve regeneration.

Abstract Image

查看原文本刊更多论文

含乌头根的聚合物纳米粒子透皮给药用于治疗化疗引起的周围神经病变

透皮纳米药物抗癌药物引起的化疗诱发周围神经病变（CIPN）会给患者带来剧烈疼痛。在编号为 2400006 的文章中，Tae Eon Park、Man-Suk Hwang 和 Ki Su Kim 开发了含有天然草药提取物的透明质酸基聚合物纳米粒子，以减轻 CIPN 引起的神经性疼痛。这些微粒可通过皮肤无创递送，促进神经再生。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Advanced Nanobiomed Research nanomedicine, bioengineering and biomaterials-

CiteScore

5.00

自引率

5.90%

发文量

审稿时长

21 weeks

期刊介绍： Advanced NanoBiomed Research will provide an Open Access home for cutting-edge nanomedicine, bioengineering and biomaterials research aimed at improving human health. The journal will capture a broad spectrum of research from increasingly multi- and interdisciplinary fields of the traditional areas of biomedicine, bioengineering and health-related materials science as well as precision and personalized medicine, drug delivery, and artificial intelligence-driven health science. The scope of Advanced NanoBiomed Research will cover the following key subject areas: ▪ Nanomedicine and nanotechnology, with applications in drug and gene delivery, diagnostics, theranostics, photothermal and photodynamic therapy and multimodal imaging. ▪ Biomaterials, including hydrogels, 2D materials, biopolymers, composites, biodegradable materials, biohybrids and biomimetics (such as artificial cells, exosomes and extracellular vesicles), as well as all organic and inorganic materials for biomedical applications. ▪ Biointerfaces, such as anti-microbial surfaces and coatings, as well as interfaces for cellular engineering, immunoengineering and 3D cell culture. ▪ Biofabrication including (bio)inks and technologies, towards generation of functional tissues and organs. ▪ Tissue engineering and regenerative medicine, including scaffolds and scaffold-free approaches, for bone, ligament, muscle, skin, neural, cardiac tissue engineering and tissue vascularization. ▪ Devices for healthcare applications, disease modelling and treatment, such as diagnostics, lab-on-a-chip, organs-on-a-chip, bioMEMS, bioelectronics, wearables, actuators, soft robotics, and intelligent drug delivery systems. with a strong focus on applications of these fields, from bench-to-bedside, for treatment of all diseases and disorders, such as infectious, autoimmune, cardiovascular and metabolic diseases, neurological disorders and cancer; including pharmacology and toxicology studies.